Minimum Investment: Call
Region Nationwide and Expanding
Industry 1: Healthcare Antiseptics
Industry 2: Personal Care Hand Sanitizer
Stage: Start-up but on retail shelves in Walgreens, Albertsons and have healthcare distribution.
Investment Reason: Manufacturing, Working Capital. We are set up with another enormous retailer but as soon as they send a Purchase Order we’ll need the capital for manufacturing.
The market is hotter than ever because of the FDA’s announcement about seeking more safety data on healthcare antiseptics.
…sales of gels and wipes in the U.S. soared more than 70% year-over-year to $118 million in the 24 weeks ended Oct. 3, 2009, at the peak of the swine flu epidemic, according to data released at the time by market research Nielsen.
Going forward, sales are expected to increase modestly to just over $226 million by 2018, the report says.
Invest In safeHands – The Future of Antiseptics
safeHands produces an alcohol-free hand sanitizer that kills 99.99% of germs and is non-toxic, non-flammable, and does not dry the skin. Hand sanitizers are a $400 million market in the US dominated by alcohol-based products. However, the alcohol-based products are being misused by teens who drink them to get intoxicated or light them on fire to do magic tricks.
Recently the FDA has expressed concerns about the long-term effects of alcohol-based hand sanitizers on healthcare workers, particularly pregnant or breastfeeding women. When used frequently, the alcohol can get into the bloodstream posing a long-term systemic risk.
As consumers and the healthcare community look for alcohol-free alternatives, safeHands is well-positioned to take its share of the market. The company’s products are carried by major retail chains. Medical distributors also carry the safeHands line, as do international distributors. The company is raising capital to fund projected rapid growth and anticipates a sale to a large consumer products company in three to five years